Breaking tolerance - Another piece added to the vitiligo puzzle

Journal of Investigative Dermatology

Volumn 124, Issue 1, 2005, Pages

  Lee, Delphine J ^a   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ALPHA INTERFERON; BETA INTERFERON; CALCINEURIN INHIBITOR; CD4 ANTIGEN; CD8 ANTIGEN; CHLORDANE; CORTICOSTEROID; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLYCOPROTEIN GP 100; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; MYELOID DIFFERENTIATION FACTOR 88; PLASMID DNA; TACROLIMUS; TOLL LIKE RECEPTOR 9; TYROSINASE RELATED PROTEIN 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIUM; BONE MARROW; BONE MARROW CELL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DEPIGMENTATION; DERMIS; DOWN REGULATION; EPIDERMIS; GENE GUN; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFLAMMATION; INJECTION; INJURY; ISOMORPHIC PHENOMENON; MACROPHAGE; MELANOCYTE; MELANOMA; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SKIN DEFECT; T LYMPHOCYTE; TH2 CELL; THYMUS; TISSUE INJURY; TUMOR REJECTION; VACCINATION; VITILIGO;

EID: 11944271723     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23553.x     Document Type: Note

References (17)

1. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P: A direct estimate of the human alphabeta T cell receptor diversity. Science 286:958-961, 1999
2. Houghton AN: Cancer antigens: Immune recognition of self and altered self. J Exp Med 180:1-4, 1994
3. Le Poole IC, Wankowicz-Kalinska A, van den Wijngaard RM, Nickoloff BJ, Das PK: Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc 9:68-72, 2004
4. Lerner AB: On the etiology of vitiligo and gray hair. Am J Med 51:141-147, 1971
5. Mahmoud F, Abul H, Haines D, Al Saleh C, Khajeji M, Whaley K: Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4 + CD45RO + and CD4 + CD25 + of T-helper cells in non-segmental vitiligo. J Dermatol 29:68-73, 2002
6. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045, 1994
7. Nagai H, Hara I, Horikawa T, Oka M, Kamidono S, Ichihashi M: Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration. J Invest Dermatol 115:1059-1064, 2000
8. Ongenae K, Van Geel N, Naeyaert JM: Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90-100, 2003
9. Paukkonen K, Naukkarinen A, Horsmanheimo M: The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c + macrophages into the epidermis. Arch Dermatol Res 284:375-379, 1992
10. Phan GQ, Yang JC, Sherry RM, et al: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 100:8372-8377, 2003
11. Roman M, Martin-Orozco E, Goodman JS, et al: Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3:849-854, 1997
12. Sakaguchi S: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562, 2004
13. Steinman L: Immune therapy for autoimmune diseases. Science 305:212-216, 2004
14. Sweet RD: Vitiligo as a Kobner phenomenon. Br J Dermatol 99:223-224, 1978
15. Tüting T, Steiz J, Brück J, Lenz J, Büchs S: Peripheral CD8+ T cell tolerance against melanocytic self antigens in the skin is regulated in two steps by CD4 + T cells and local inflammation: Implications for the pathophysiology of vitiligo. J Invest Dermatol 124:144-150, 2005
16. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254:277-279, 1991
17. Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M: IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J Immunol 164:3563-3572, 2000